Russian vaccine offers 92% protection, according to phase III clinical trial data published by The Lancet
1 min
Russia's Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal. The vaccine was approved on August 11th just after the results of the phase II trial. Russia started its immunisation campaign at the beginning of December.
